Pharmaceutical Cannabis - Uganda

Uganda

In Uganda, revenue in the Pharmaceutical Cannabis market is forecasted to reach US$1.30m in 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 4.63%, leading to a market volume of US$1.63m by 2029.
When compared globally, the United States is expected to generate the highest revenue (US$913.10m in 2024).
In terms of per person revenues in 2024, US$1.64k are generated in relation to the total population figures.
Uganda's pharmaceutical cannabis market is gaining traction with increasing research and development initiatives to harness its medicinal properties.

Key regions: United States, Spain, Europe, Thailand, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceutical Cannabis market in Uganda has been experiencing significant growth and development in recent years.

Customer preferences: Customers in Uganda are increasingly turning to Pharmaceutical Cannabis products due to the growing awareness of its potential health benefits. With a shift towards natural and alternative remedies, there is a rising demand for Pharmaceutical Cannabis products in the country.

Trends in the market: One of the key trends in the Pharmaceutical Cannabis market in Uganda is the increasing number of local companies entering the industry. These companies are capitalizing on the favorable regulatory environment and the abundant resources available in the country to produce high-quality Pharmaceutical Cannabis products. Additionally, there is a growing trend towards research and development in the sector, leading to the introduction of innovative Pharmaceutical Cannabis products tailored to the needs of the local market.

Local special circumstances: Uganda's favorable climate and rich soil make it an ideal location for Pharmaceutical Cannabis cultivation. The country's geographic location also provides easy access to regional markets, making it a strategic hub for Pharmaceutical Cannabis production and distribution in East Africa. Moreover, the government's supportive stance towards the Pharmaceutical Cannabis industry, including the establishment of regulatory frameworks, has created a conducive environment for market growth.

Underlying macroeconomic factors: The Pharmaceutical Cannabis market in Uganda is also influenced by broader macroeconomic factors such as increasing disposable income levels and changing consumer preferences. As the economy continues to grow, more Ugandans have the purchasing power to invest in Pharmaceutical Cannabis products for medicinal or recreational purposes. Additionally, the evolving regulatory landscape and government support are attracting foreign investments into the Pharmaceutical Cannabis sector, further driving market expansion.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.